MedTrace Logo

Second Bowel Preparation for Colonoscopy Failure

NCT01510977 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2013-02-13

No results posted yet for this study

Summary

Colonoscopy is a basic but important tool to diagnose and treat lesions of the colon. Proper colon cleansing is essential for colonoscopy to be performed with a good quality. Inadequate bowel preparation leads to longer colonoscopic insertion time and patient discomfort, as well as inadequate diagnostic yield of colonic lesions. Frequency of colonoscopy failure due to bad bowel preparation is reported to be 0.3% to 6.5 percent, and the rate increases with liver cirrhosis, constipation, dementia, stroke, or administration of tricyclic antidepressants. In case of colonoscopy failure due to bad bowel preparation, the second colonoscopy can be performed with either adding a colon cleansing solution immediately, or it can be performed after a few days with colon cleansing agent together with prokinetics. These different kinds of bowel preparations after first colonoscopy failure have not been compared.

Conditions

  • Colonoscopy Failure
  • Poor Bowel Preparation

Interventions

DRUG

polyethylene glycol, Bisacodyl

After failure of first colonoscopy, bowel preparation with polyethylene glycol and bisacodyl one week after

DRUG

polyethylene glycol

Immediately after first colonoscopy failure, polyethylene glycol 2L addition

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Jeong-Sik Byeon, MD, PhD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01510977 on ClinicalTrials.gov